ReviewMaterials today. Bio2025
Stimuli-responsive hybrid materials for 4D
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Near-Infrared Light-Driven Microgrooved UCNPs/Azobenzene-LCE Actuators and Substrates for Cardiomyoblast Alignment.ACS applied materials & interfaces · 2026Article
- Smart and stimuli-responsive hydrogels for controlled exosome delivery in bone tissue engineering: from passive carriers to intelligent therapeutic platforms.Cell and tissue banking · 2026Review
- Engineering Silk Fibroin-Based Biomaterials for Neural Repair.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Advanced Mathematical Platform for the Control and Manipulation of Magnetized Living Cells.Bioengineering (Basel, Switzerland) · 2026Article
- 4D morphogenetic tissue engineering via gradient-crosslinked microporous hydrogel scaffolds.Materials today. Bio · 2026Article
- Rational Design and Functionalization of Melt Electrowritten 4D Scaffolds for Biomedical Applications.Nano-micro letters · 2026Review
- Advancing transdermal drug delivery through 4D bioprinting and dynamic skin modelling.Frontiers in drug delivery · 2026Review
- The cutting-edge advancements in biomaterials under the guidance of intelligence and bionics.Regenerative biomaterials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is an existing need to develop 3D tissue models which correctly recapitulate healthy and diseased states. The most commonly used techniques focus on simplistic 2D cell culture techniques, themselves incapable of transmitting the complexity of multi-tissue arrangements, and archaic and unnecessary animal models which fail to reproduce species-dependent aspects. The advances in materials science and engineering approaches have opened the possibility to realistically design and even print, in 3D, complex tissue arrangements, aiming to reach full-scale organ printing. Significant improvements have been noted on the spatial and temporal scale, with excellent resolution and overall size being achieved, in addition to models with extensive lifespans. The application of 3D printing to achieve such models has been extensively reviewed. However, there remains an important lack of integration of physical and mechanical cues to achieve tissue responsiveness, aimed to mimic physiological conditions that occur frequently. With this in mind, we have conducted an extensive review of the literature related to stimuli-responsive materials compatible with 3D (bio)printing techniques. Such materials, often termed hybrid materials due to the combination of organic matrices with inorganic actuators, provide "life" to materials, thus adding an extra dimension to the printing technique and coining the term 4D (bio)printing. Examples of healthy cardiovascular, musculoskeletal and neural tissue models that specifically require the incorporation of dynamic features and pathological models are included.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.